Dosis vaksin dengue perlu dipenuhi agar efektif miliki kekebalan DBD

Dengue fever, also known as DBD, is a serious and potentially deadly disease that is transmitted by mosquitoes. In Indonesia, dengue fever is a major public health concern, with thousands of cases reported every year. One of the most effective ways to prevent the spread of dengue fever is through vaccination.

Vaccination against dengue fever has been proven to be highly effective in preventing the disease. However, in order for the vaccine to be effective, it is crucial that individuals receive the recommended dosage of the vaccine. The dengue fever vaccine is typically administered in two doses, with the second dose given 6-12 months after the first dose.

It is important to ensure that individuals receive both doses of the vaccine in order to achieve maximum protection against dengue fever. Studies have shown that individuals who receive both doses of the vaccine have a significantly lower risk of developing severe dengue fever compared to those who only receive one dose or none at all.

In order to achieve herd immunity and effectively prevent the spread of dengue fever, it is essential that a high percentage of the population receive the recommended dosage of the vaccine. This can help to reduce the overall burden of dengue fever in Indonesia and protect vulnerable populations, such as children and the elderly, from the potentially deadly effects of the disease.

In conclusion, ensuring that individuals receive the recommended dosage of the dengue fever vaccine is crucial in order to achieve effective immunity against DBD. By vaccinating a high percentage of the population, we can help to prevent the spread of dengue fever and protect the health and well-being of all Indonesians.